Several novel solutions are now available in the Britain for treating type 2 diabetes . copyright , Metformin, and Mounjaro represent distinct approaches, with Saxenda and Trulicity being injectable peptide receptor activators primarily aimed at weight management alongside blood sugar stabilizati